Earnings · China A-shares
Hunan Er-Kang Pharmaceutical Co., Ltd. Class A (300267) earnings
Hunan Er-Kang Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +83.00% year on year, +112.72% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +3.53% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +83.00%
- Excl. one-offs YoY
- +112.72%
- Net profit QoQ
- -10.86%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +2.12% | — |
| 3 days | +3.53% | — |
| 7 days | +3.89% | — |
| 14 days | -3.53% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 3 of 7 reports (average +3.75%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥72.42M | +83.00% | +112.72% | -5.99% | 0.04 | 1.79% | +3.53% | — | — |
| 2026 interim report | 2026-08-27 | ¥44.47M | +18.16% | +24.75% | -16.77% | 0.02 | 1.11% | -0.60% | -6.31% | +2.63% |
| 2026 Q1 report | 2026-04-24 | ¥13.11M | -53.37% | -55.63% | -30.03% | 0.01 | 0.33% | -4.22% | -20.37% | -20.79% |
| 2025 annual report | 2026-04-23 | -¥379.82M | -1.73% | -4.61% | +2.29% | -0.18 | -8.96% | -0.98% | -19.51% | -17.96% |
| 2025 Q3 report | 2025-10-30 | ¥39.58M | +255.40% | +209.65% | +17.81% | 0.02 | 0.89% | +3.71% | +3.14% | +7.89% |
| 2025 interim report | 2025-08-28 | ¥37.63M | +497.36% | +1357.97% | +9.74% | 0.02 | 0.85% | -0.26% | -11.48% | -16.98% |
| 2025 Q1 report | 2025-04-23 | ¥28.11M | +868.91% | +839.24% | +28.19% | 0.01 | 0.63% | +25.10% | +41.56% | +38.52% |
| 2024 annual report | 2025-04-23 | -¥373.37M | -91.16% | -59.24% | -36.09% | -0.18 | -8.04% | +25.10% | +41.56% | +38.52% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.